Dyne Therapeutics
94 hedge funds and large institutions have $457M invested in Dyne Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 32 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $568M → $457M (-$111M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
22% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 32
Holders
94
Holding in Top 10
4
Calls
$8K
Puts
$1K
Top Buyers
| 1 | +$11.6M | |
| 2 | +$6.27M | |
| 3 | +$6.1M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$5.78M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$2.88M |
Top Sellers
| 1 | -$16.1M | |
| 2 | -$10M | |
| 3 | -$4.82M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.03M |
| 5 |
ACM
Altium Capital Management
New York
|
-$1.98M |